Cooper Companies (NASDAQ:COO) Hits New 12-Month Low - Should You Sell?

Key Points

• Price action: Cooper Companies hit a new 52-week low of $60.52 (last ~$60.18) and is trading well below its 50-day ($72.07) and 200-day ($76.23) moving averages.
• Analyst backdrop: Broker views are mixed but the consensus is a Moderate Buy with an average target of $90.79, despite recent downgrades and some firms raising targets to the low-$100s.
• Fundamentals: Q1 EPS of $1.10 beat estimates and revenue rose 6.2% year-over-year; management set Q2 FY2026 guidance of 4.580–4.660 EPS and the company carries low leverage (debt/equity 0.22).

The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report)'s stock price reached a new 52-week low on Wednesday . The stock traded as low as $60.52 and last traded at $60.1760, with a volume of 171882 shares traded. The stock had previously closed at $61.25.

Analysts Set New Price Targets

Several analysts have weighed in on COO shares. Rothschild & Co Redburn downgraded shares of Cooper Companies from a "buy" rating to a "neutral" rating and set a $85.00 target price on the stock. in a research report on Wednesday, March 4th. Citigroup dropped their target price on shares of Cooper Companies from $88.00 to $87.00 and set a "neutral" rating on the stock in a research report on Friday, March 6th. Wall Street Zen raised shares of Cooper Companies from a "hold" rating to a "buy" rating in a research report on Saturday, February 28th. Needham & Company LLC lifted their price objective on shares of Cooper Companies from $99.00 to $101.00 and gave the company a "buy" rating in a research note on Friday, March 6th. Finally, Barclays lifted their price objective on shares of Cooper Companies from $98.00 to $103.00 and gave the company an "overweight" rating in a research note on Friday, March 6th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Cooper Companies has a consensus rating of "Moderate Buy" and an average target price of $90.79.

Cooper Companies Stock Performance

The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34. The firm's 50 day simple moving average is $72.07 and its 200 day simple moving average is $76.23. The firm has a market capitalization of $11.93 billion, a price-to-earnings ratio of 30.26, a PEG ratio of 1.59 and a beta of 0.89.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.03 by $0.07. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The firm had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $1.02 billion. During the same period in the previous year, the business posted $0.92 EPS. The business's revenue was up 6.2% compared to the same quarter last year. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Sell-side analysts forecast that The Cooper Companies, Inc. will post 4.62 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Cooper Companies

Several large investors have recently made changes to their positions in the company. New York Life Investment Management LLC lifted its stake in shares of Cooper Companies by 0.6% in the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company's stock valued at $2,241,000 after purchasing an additional 158 shares during the period. Root Financial Partners LLC lifted its stake in shares of Cooper Companies by 104.5% in the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company's stock valued at $26,000 after purchasing an additional 162 shares during the period. Allworth Financial LP lifted its stake in shares of Cooper Companies by 14.1% in the 4th quarter. Allworth Financial LP now owns 1,355 shares of the medical device company's stock valued at $111,000 after purchasing an additional 167 shares during the period. Mesirow Financial Investment Management Inc. lifted its stake in shares of Cooper Companies by 1.3% in the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company's stock valued at $961,000 after purchasing an additional 175 shares during the period. Finally, Blue Trust Inc. lifted its stake in shares of Cooper Companies by 13.9% in the 4th quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company's stock valued at $124,000 after purchasing an additional 185 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Company Profile

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.